ODI Pharma AB (publ) (NGM:ODI)
Sweden · Delayed Price · Currency is SEK 3.000
+0.020 (0.67%)
At close: Jun 12, 2026
ODI Pharma AB Income Statement
Financials in millions SEK. Fiscal year is July - June.
Millions SEK. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 29.82 | 3.13 | 22.29 | 0.14 | 0.31 | - | |
Revenue Growth (YoY) | 182.05% | -85.94% | 15880.34% | -55.44% | - | - |
Cost of Revenue | 21.2 | 2.29 | 17.66 | 0.86 | 0.42 | - |
Gross Profit | 8.62 | 0.84 | 4.62 | -0.72 | -0.1 | - |
Selling, General & Admin | 8.04 | 6.11 | 6.54 | 6.09 | 7.12 | 3.92 |
Other Operating Expenses | 0.44 | 0.18 | -2.35 | -0 | -0.02 | 0.04 |
Operating Expenses | 8.48 | 6.29 | 4.19 | 6.09 | 7.1 | 3.96 |
Operating Income | 0.14 | -5.45 | 0.43 | -6.81 | -7.21 | -3.96 |
Interest Expense | -0.7 | -0.74 | -0.86 | -0.11 | -0.03 | -0.01 |
Interest & Investment Income | 0.2 | 0.26 | 0.05 | 0.02 | 0 | 0.01 |
Other Non Operating Income (Expenses) | 0 | 0 | - | - | - | - |
Pretax Income | -0.36 | -5.93 | -0.38 | -6.9 | -7.24 | -3.97 |
Income Tax Expense | 0 | 0 | 0.19 | 0.01 | 0 | 0.01 |
Net Income | -0.36 | -5.93 | -0.57 | -6.9 | -7.24 | -3.98 |
Net Income to Common | -0.36 | -5.93 | -0.57 | -6.9 | -7.24 | -3.98 |
Shares Outstanding (Basic) | 20 | 19 | 15 | 15 | 15 | 15 |
Shares Outstanding (Diluted) | 20 | 19 | 15 | 15 | 15 | 15 |
Shares Change (YoY) | 29.38% | 21.82% | -0.76% | 1.69% | -1.52% | 11.10% |
EPS (Basic) | -0.02 | -0.32 | -0.04 | -0.45 | -0.48 | -0.26 |
EPS (Diluted) | -0.02 | -0.32 | -0.04 | -0.45 | -0.48 | -0.26 |
Free Cash Flow | 2.4 | -3.31 | -3.82 | -5.1 | -7.38 | -6.06 |
Free Cash Flow Per Share | 0.12 | -0.18 | -0.25 | -0.33 | -0.49 | -0.40 |
Gross Margin | 28.90% | 26.77% | 20.74% | - | -33.12% | - |
Operating Margin | 0.47% | -173.94% | 1.92% | -4884.20% | -2302.98% | - |
Profit Margin | -1.22% | -189.33% | -2.55% | -4948.58% | -2313.25% | - |
Free Cash Flow Margin | 8.05% | -105.49% | -17.16% | -3659.83% | -2357.80% | - |
EBITDA | 0.14 | -5.45 | 0.43 | -6.81 | -7.2 | -3.96 |
EBITDA Margin | 0.48% | -173.88% | 1.93% | - | - | - |
D&A For EBITDA | 0 | 0 | 0 | 0 | 0.01 | 0.01 |
EBIT | 0.14 | -5.45 | 0.43 | -6.81 | -7.21 | -3.96 |
EBIT Margin | 0.47% | -173.94% | 1.92% | - | - | - |
Revenue as Reported | 30.24 | 3.45 | 25.33 | 0.18 | 0.4 | 0.02 |